Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.3
8080 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Goldman Sachs Talks
View all
WSJ Tech News Briefing
1,654 Listeners
The McKinsey Podcast
381 Listeners
Bloomberg Intelligence
397 Listeners
Masters in Business
2,162 Listeners
Goldman Sachs Exchanges
985 Listeners
Odd Lots
1,697 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,332 Listeners
Behind the Money
216 Listeners
UBS On-Air: Market Moves
170 Listeners
Making Sense
59 Listeners
Thoughts on the Market
1,264 Listeners
Global Data Pod
15 Listeners
In Good Company with Nicolai Tangen
176 Listeners
Goldman Sachs The Markets
76 Listeners
WSJ's Take On the Week
116 Listeners